ECSP066476A - Preparación de una infusión que comprende ácido (2r)-2-propiloctanoico como ingrediente activo - Google Patents
Preparación de una infusión que comprende ácido (2r)-2-propiloctanoico como ingrediente activoInfo
- Publication number
- ECSP066476A ECSP066476A EC2006006476A ECSP066476A ECSP066476A EC SP066476 A ECSP066476 A EC SP066476A EC 2006006476 A EC2006006476 A EC 2006006476A EC SP066476 A ECSP066476 A EC SP066476A EC SP066476 A ECSP066476 A EC SP066476A
- Authority
- EC
- Ecuador
- Prior art keywords
- infusion
- propyloctanoic
- preparation
- active ingredient
- salt
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención se refiere a una preparación de infusión la cual es útil para enfermedades neurodegenerativas, la cual comprende ácido (2R)-2-propiloctanoico o una sal del mismo y un ión metálico básico el cual se suministra a partir de una sal metálica o un hidróxido metálico de ácido débil, preferiblemente de aproximadamente 1 a aproximadamente 5 equivalentes de un ión metálico básico tomando como referencia 1 equivalente de ácido (2R)-2-propiloctanoico o una sal del mismo, y opcionalmente comprende otros componentes de infusión. La preparación de infusión de la presente invención tiene un pH apropiado para administración intravenosa, y es útil para administración intravenosa dado que no requiere ninguna operación preparatoria tal como disolución, dilución o similares en el momento de uso.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003345125 | 2003-10-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP066476A true ECSP066476A (es) | 2007-03-29 |
Family
ID=34419442
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2006006476A ECSP066476A (es) | 2003-10-03 | 2006-04-03 | Preparación de una infusión que comprende ácido (2r)-2-propiloctanoico como ingrediente activo |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20070066686A1 (es) |
| EP (1) | EP1669066A4 (es) |
| JP (1) | JP4715516B2 (es) |
| CN (1) | CN1889941A (es) |
| AU (1) | AU2004277828A1 (es) |
| BR (1) | BRPI0414968A (es) |
| CA (1) | CA2540671A1 (es) |
| EC (1) | ECSP066476A (es) |
| IL (1) | IL174691A0 (es) |
| IS (1) | IS8428A (es) |
| MA (1) | MA28143A1 (es) |
| MX (1) | MXPA06003605A (es) |
| NO (1) | NO20061458L (es) |
| RU (1) | RU2006114834A (es) |
| SG (1) | SG146690A1 (es) |
| WO (1) | WO2005032538A1 (es) |
| ZA (1) | ZA200602689B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7980168B2 (en) * | 2007-06-26 | 2011-07-19 | Maurer Scott D | Hot beverage maker with filter deforming member |
| US20100130619A1 (en) * | 2008-11-24 | 2010-05-27 | Joseph Schwarz | Pharmaceutical composition for parenteral administration of idebenone |
| RU2549448C1 (ru) * | 2014-05-20 | 2015-04-27 | Екофарм Патент Менеджмент Аг | Сбалансированный инфузионный раствор |
| CN104931424A (zh) * | 2015-05-06 | 2015-09-23 | 山东师范大学 | 一种改进的z扫描非线性测量的实验装置及方法 |
| CN109593676B (zh) * | 2018-12-21 | 2023-04-07 | 江苏大学 | 一种用于酸菜发酵液中微生物分离的培养基及其制备方法 |
| WO2020168191A1 (en) * | 2019-02-14 | 2020-08-20 | North Grove Investments, Inc. | Compositions for maintaining the viability of living and static biological material, methods of making and the uses thereof |
| RU2699222C1 (ru) * | 2019-04-29 | 2019-09-04 | Алексей Владимирович Воронов | Солевой электролитный раствор для проведения энтеральных инфузий |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE163006T1 (de) * | 1993-06-01 | 1998-02-15 | Ono Pharmaceutical Co | Pentansäurederivate |
| JPH0782146A (ja) * | 1993-07-23 | 1995-03-28 | Sagami Chem Res Center | 抗痴呆薬 |
| JPH07285911A (ja) * | 1994-04-20 | 1995-10-31 | New Japan Chem Co Ltd | 脂肪族モノカルボン酸組成物 |
| JPH0853351A (ja) * | 1994-08-11 | 1996-02-27 | Sagami Chem Res Center | 酵素阻害剤、血管新生抑制剤、および癌転移抑制剤 |
| US6043223A (en) * | 1997-11-12 | 2000-03-28 | The Regents Of The University Of California | Enhanced opening of abnormal brain tissue capillaries |
| TWI268921B (en) * | 1999-02-18 | 2006-12-21 | Ono Pharmaceutical Co | A process for preparing (2R)-2-propyloctanoic acid |
| EP1295893A4 (en) * | 2000-05-31 | 2005-10-26 | Japan Science & Tech Agency | GINSENOSIDES FOR PROMOTING SKIN WEBERENEGENERATION |
| JP4706950B2 (ja) * | 2000-07-18 | 2011-06-22 | 小野薬品工業株式会社 | アストロサイト機能改善剤を有効成分として含有するパーキンソン病治療剤 |
| KR100759771B1 (ko) * | 2000-07-18 | 2007-10-04 | 오노 야꾸힝 고교 가부시키가이샤 | 성상세포 기능 개선제를 유효 성분으로 함유하는 파킨슨병치료제 |
| EP1415668A4 (en) * | 2001-07-18 | 2007-08-29 | Ono Pharmaceutical Co | REMEDIES AGAINST BRAIN ISCHEMIC DISEASES |
-
2004
- 2004-10-01 WO PCT/JP2004/014896 patent/WO2005032538A1/ja active Application Filing
- 2004-10-01 RU RU2006114834/15A patent/RU2006114834A/ru not_active Application Discontinuation
- 2004-10-01 US US10/574,476 patent/US20070066686A1/en not_active Abandoned
- 2004-10-01 CA CA002540671A patent/CA2540671A1/en not_active Abandoned
- 2004-10-01 JP JP2005514508A patent/JP4715516B2/ja not_active Expired - Fee Related
- 2004-10-01 AU AU2004277828A patent/AU2004277828A1/en not_active Abandoned
- 2004-10-01 MX MXPA06003605A patent/MXPA06003605A/es not_active Application Discontinuation
- 2004-10-01 BR BRPI0414968-8A patent/BRPI0414968A/pt not_active IP Right Cessation
- 2004-10-01 SG SG200807295-1A patent/SG146690A1/en unknown
- 2004-10-01 CN CNA2004800356843A patent/CN1889941A/zh active Pending
- 2004-10-01 EP EP04792178A patent/EP1669066A4/en not_active Withdrawn
-
2006
- 2006-03-30 IL IL174691A patent/IL174691A0/en unknown
- 2006-03-31 ZA ZA200602689A patent/ZA200602689B/en unknown
- 2006-03-31 NO NO20061458A patent/NO20061458L/no not_active Application Discontinuation
- 2006-04-03 EC EC2006006476A patent/ECSP066476A/es unknown
- 2006-04-25 IS IS8428A patent/IS8428A/is unknown
- 2006-05-02 MA MA28992A patent/MA28143A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP4715516B2 (ja) | 2011-07-06 |
| AU2004277828A1 (en) | 2005-04-14 |
| SG146690A1 (en) | 2008-10-30 |
| EP1669066A1 (en) | 2006-06-14 |
| MXPA06003605A (es) | 2006-06-14 |
| IS8428A (is) | 2006-04-25 |
| BRPI0414968A (pt) | 2006-11-07 |
| RU2006114834A (ru) | 2007-11-20 |
| MA28143A1 (fr) | 2006-09-01 |
| CA2540671A1 (en) | 2005-04-14 |
| WO2005032538A1 (ja) | 2005-04-14 |
| US20070066686A1 (en) | 2007-03-22 |
| JPWO2005032538A1 (ja) | 2006-12-14 |
| EP1669066A4 (en) | 2009-04-29 |
| IL174691A0 (en) | 2006-08-20 |
| NO20061458L (no) | 2006-07-03 |
| CN1889941A (zh) | 2007-01-03 |
| ZA200602689B (en) | 2007-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP066477A (es) | Composición farmacéutica que comprende ácido (2r)-2-propiloctanoico como un ingrediente activo | |
| ECSP066476A (es) | Preparación de una infusión que comprende ácido (2r)-2-propiloctanoico como ingrediente activo | |
| ES2545959T3 (es) | Un medicamento consistente en un derivado de carboestirilo y donepezilo para el tratamiento de la enfermedad de Alzheimer | |
| AR033175A1 (es) | Usos farmaceuticos de bisfosfonatos | |
| AR105712A1 (es) | Composiciones de insulina de rápida acción | |
| EA200800258A1 (ru) | Эмульсионные композиции пропофола для внутривенного введения, имеющие консервирующую эффективность | |
| EP2548552A3 (en) | Titration package for 1-amino-alkylcylohexanes | |
| CL2010000188A1 (es) | Metodo para el tratamiento de una infeccion en un sujeto que comprende la administracion de 9-[(2,2-dimetil-propilamino)-metil]-minociclina o de una sal de la misma; composicion farmaceutica que comprende dicho compuesto; y su uso. | |
| AR054141A1 (es) | Terapia combinada para el tratamiento de trastornos inmunoinflamatorios | |
| CO6290622A2 (es) | Composiciones de activo antitranspirante con un cromatograma sec que presenta una elevada intensidad de pico 4 sec para reducir la transpiración | |
| BRPI0507684B8 (pt) | agentes de contraste para imagem de perfusão miocárdica | |
| CO5580776A2 (es) | Formulacion farmaceutica estable en solucion de oxaliplatino | |
| BRPI0418330A (pt) | composições sólidas de drogas de solubilidade baixa e poloxámeros | |
| CL2011000135A1 (es) | Uso de una fromulacion farmaceutica acuosa que comprende 0,5-10% de terbinafina o una sal de la misma, 2-10% de un fosfolipido y 1-5% de un surfactante, para preparar un medicamento util para tratar una infeccion fungica; formulacion farmaceutica. | |
| EA200501105A1 (ru) | Фармацевтическая композиция | |
| RU2010136914A (ru) | Средство и продукт питания для профилактики/уменьшения проявлений функционального расстройства пищеварения | |
| CY1109120T1 (el) | Φαρμακευτικη συνθεση βινφλουνινης που προοριζεται για παρεντερικη χορηγηση, μεθοδος παρασκευης και χρησης | |
| MX2019001850A (es) | Formulaciones para administracion oral de principios activos. | |
| BR112019023981A2 (pt) | injeção de octreotida | |
| BR0308316A (pt) | Sais de nateglinida | |
| PH12019500618A1 (en) | Pharmaceutical composition and method for treatment of non-alcoholic fatty liver disease | |
| BRPI0414822A (pt) | método de inibir a produção de lipoproteìna remanescente | |
| DOP2005000052A (es) | Preparacion de infusión que comprende acido (2r)-2-propilactanoico como un ingrediente activo | |
| AR048821A1 (es) | "preparacion de infusion que comprende acido (2r)-2-propiloctanoico como un ingrediente activo y recipiente" | |
| RU2006109966A (ru) | Препарат "янтастим-с" для терапии и профилактики инфекционных заболеваний животных |